Next Article in Journal
Acceptability of Condoms, Circumcision and PrEP among Young Black Men Who Have Sex with Men: A Descriptive Study Based on Effectiveness and Cost
Previous Article in Journal
Meningitis in a School-Aged Child due to Haemophilus influenzae Type E during the Post-Conjugate Vaccine Era—Monroe County, NY, 2011
Previous Article in Special Issue
Development of Streptococcus pneumoniae Vaccines Using Live Vectors
Vaccines 2014, 2(1), 112-128; doi:10.3390/vaccines2010112

Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention

1,* , 2
1 Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA 2 National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA 3 Departments of Microbiology and Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
* Author to whom correspondence should be addressed.
Received: 2 December 2013 / Revised: 18 January 2014 / Accepted: 6 February 2014 / Published: 14 February 2014
(This article belongs to the Special Issue Pneumococcal Vaccine in the 21st Century)
View Full-Text   |   Download PDF [336 KB, uploaded 14 February 2014]


Seven-valent pneumococcal conjugate vaccine (PCV7) introduction and routine pediatric use has substantially reduced the burden of Streptococcus pneumoniae disease worldwide. However, a significant amount of disease burden, due to serotypes not contained in PCV7, still exists globally. A newly recognized serotype, 6C, was until recently, identified and reported as serotype 6A. This review summarizes the serotype epidemiology of pneumococcal disease pre- and post-introduction of PCV7, available post-marketing surveillance data following the introduction of higher valency pneumococcal vaccines (PCV10, PCV13) and future prospects for the development of new pneumococcal vaccines.
Keywords: Streptococcus pneumoniae; vaccine; epidemiology; serotype; pneumococcal protein Streptococcus pneumoniae; vaccine; epidemiology; serotype; pneumococcal protein
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Lee, L.H.; Gu, X.-X.; Nahm, M.H. Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention. Vaccines 2014, 2, 112-128.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert